anmelden
SMI
13.281,67
PKT
+229,50
PKT
+1,76
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.09.11 | Lonza hold | Vontobel Research | |
| 14.09.11 | Novartis buy | Société Générale Group S.A. (SG) | |
| 14.09.11 | Novartis buy | Vontobel Research | |
| 14.09.11 | Lonza hold | Vontobel Research | |
| 12.09.11 | Swiss Re buy | Vontobel Research | |
| 12.09.11 | Lonza hold | Vontobel Research | |
| 09.09.11 | Novartis outperform | Credit Suisse Group | |
| 09.09.11 | UBS overweight | Morgan Stanley | |
| 09.09.11 | Sika buy | UBS AG | |
| 09.09.11 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 09.09.11 | Sika buy | Vontobel Research | |
| 09.09.11 | Lonza hold | Vontobel Research | |
| 08.09.11 | Givaudan overweight | J.P. Morgan Cazenove | |
| 08.09.11 | Holcim buy | UBS AG | |
| 08.09.11 | Holcim neutral | J.P. Morgan Cazenove | |
| 08.09.11 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 08.09.11 | Holcim neutral | Nomura | |
| 08.09.11 | Novartis buy | Vontobel Research | |
| 08.09.11 | UBS hold | Vontobel Research | |
| 07.09.11 | UBS outperform | Keefe, Bruyette & Woods, Inc. | |
| 07.09.11 | UBS outperform | Keefe, Bruyette & Woods, Inc. | |
| 07.09.11 | Richemont buy | Citigroup Corp. | |
| 07.09.11 | Nestlé hold | UniCredit Research | |
| 06.09.11 | UBS overweight | J.P. Morgan Cazenove | |
| 06.09.11 | Zurich Insurance buy | Citigroup Corp. | |
| 06.09.11 | Nestlé buy | Banc of America Securities-Merrill Lynch | |
| 06.09.11 | Partners Group hold | Vontobel Research | |
| 06.09.11 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 05.09.11 | Zurich Insurance overweight | J.P. Morgan Cazenove | |
| 05.09.11 | UBS neutral | UBS AG | |
| 05.09.11 | ABB (Asea Brown Boveri) neutral | HSBC | |
| 05.09.11 | UBS kaufen | Die Actien-Börse | |
| 05.09.11 | Novartis buy | Vontobel Research | |
| 02.09.11 | Kühne + Nagel International buy | Deutsche Bank AG | |
| 01.09.11 | Givaudan hold | Vontobel Research | |
| 01.09.11 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 31.08.11 | UBS halten | Hamburger Sparkasse AG (Haspa) | |
| 31.08.11 | Givaudan hold | Vontobel Research | |
| 31.08.11 | Nestlé buy | Vontobel Research | |
| 31.08.11 | Novartis buy | Deutsche Bank AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.